2025年全球甲状腺癌诊断市场报告

预计未来几年甲状腺癌诊断市场规模将强劲成长。到 2029 年，这一数字将成长至 40.1 亿美元，复合年增长率为 6.2%。预测期内的成长归因于伴同性诊断需求的增加、患者对个人化医疗的偏好增加、经济成长和医疗保健支出、医生教育和培训以及监管部门的核准和许可。预测期内的全球趋势包括液态切片、诊断技术全球化、技术进步、研发、人工智慧整合、合作和伙伴关係。

随着甲状腺癌病例数量预计会增加，甲状腺癌诊断市场预计也会扩大。甲状腺癌是一种影响甲状腺的疾病，早期发现对于改善治疗效果至关重要。诊断工具在甲状腺癌的早期发现中发挥关键作用，满足了对有效诊断解决方案日益增长的需求。根据美国癌症协会 2023 年 9 月的报告，预计 2023 年将新增 43,720 例甲状腺癌病例，凸显了诊断技术进步的必要性。报告也预测，同年将有约 2,120 人死于甲状腺癌。因此，甲状腺癌盛行率的上升是推动甲状腺癌诊断市场发展的关键因素。

医疗保健支出的增加将进一步促进甲状腺癌诊断市场的发展。医疗保健支出包括分配给医疗保健服务的财政资源，是影响诊断市场动态的关键因素。医疗保健领域投资的增加促进了先进诊断技术的研究、开发和采用。这项投资将提高创新工具的可近性和可负担性，以促进甲状腺癌的早期发现和改善管理。美国医疗保险和医疗补助服务中心发布的《2021-2030年全国医疗保健支出报告》显示，预计2021年至2030年全国医疗保健支出的年复合成长率将达到5.1%，总额约为6.8兆美元。具体来看医疗保险和医疗补助，预计支出年增率分别为 7.2% 和 5.6%。因此，增加医疗保健支出是推动甲状腺癌诊断市场成长的关键因素。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、新冠疫情、经济復苏对市场的影响

第五章 全球成长分析与策略分析框架

• 全球甲状腺癌诊断PESTEL分析（政治、社会、科技、环境、法律、驱动因素、限制因素）
• 最终用途产业分析
• 全球甲状腺癌诊断市场：成长率分析
• 全球甲状腺癌诊断市场表现：规模与成长，2019-2024
• 全球甲状腺癌诊断市场预测：规模与成长，2024-2029 年，2034 年
• 全球甲状腺癌诊断总体目标市场（TAM）

第六章市场区隔

• 全球甲状腺癌诊断市场（依技术类型、表现及预测），2019-2024 年、2024-2029 年、2034 年
• 影像检查
• 血液检查
• 切片检查
• 其他测试类型
• 全球甲状腺癌诊断市场：依疾病类型、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 乳头状癌
• 滤泡性癌
• 其他疾病
• 全球甲状腺癌诊断市场：按最终用户、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 医院检查室
• 癌症诊断中心
• 研究组织
• 其他最终用户
• 全球甲状腺癌诊断市场、影像检查细分、类型、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）
• 超音波影像
• 电脑断层扫描 (CT)
• 磁振造影（MRI）
• 正子断层扫描（PET）
• 放射性碘扫描
• 全球甲状腺癌诊断市场，依血液检测类型细分，绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 甲状腺功能检查
• 肿瘤标记检测
• 甲状腺癌基因检测
• 全球甲状腺癌诊断市场、切片检查细分、类型、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）
• 细针抽吸细胞学检查（FNA）
• 芯针切片
• 手术切片检查
• 全球甲状腺癌诊断市场，按其他检测类型细分，按类型、实际和预测，2019-2024 年、2024-2029 年、2034 年
• 分子诊断
• 免疫组织化学
• 组织病理学分析

第七章 区域和国家分析

• 全球甲状腺癌诊断市场：依地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 全球甲状腺癌诊断市场：依国家、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

• 甲状腺癌诊断市场：竞争格局
• 甲状腺癌诊断市场：公司简介
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • General Electric Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Novartis International AG Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

• Sanofi SA
• Bristol-Myers Squibb Company
• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• GlaxoSmithKline plc
• Eli Lilly and Company
• Toshiba Corporation
• Merck KGaA
• Siemens Healthcare GmbH
• FUJIFILM Holdings Corporation
• Koninklijke Philips NV
• AstraZeneca plc
• Agilent Technologies Inc.
• Hologic Inc.
• Genzyme Corporation

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

• 2029年甲状腺癌诊断市场：提供新机会的国家
• 2029年甲状腺癌诊断市场：细分市场带来新机会
• 2029年甲状腺癌诊断市场：成长策略
  • 基于市场趋势的策略
  • 竞争对手的策略

第36章 附录

Thyroid cancer diagnostics involves the use of techniques to examine a lump or nodule suspected of being thyroid cancer, aiding in the identification and diagnosis of thyroid cancer. Thyroid cancer is a type of cancer that originates in the thyroid gland when cells undergo uncontrolled growth.

The primary techniques used in thyroid cancer diagnostics include imaging tests, blood tests, biopsies, and other diagnostic procedures. Imaging involves creating visual representations of phenomena such as temperature, sound waves, chemicals, or electrical activity. In the context of thyroid cancer diagnostics, imaging tests are utilized to generate images of the thyroid gland. Different types of thyroid cancer include papillary carcinoma, follicular carcinoma, and others. These diagnostic techniques are employed by various end-users, including hospital laboratories, cancer diagnostic centers, research institutes, and others.

The thyroid cancer diagnostics market research report is one of a series of new reports from The Business Research Company that provides thyroid cancer diagnostics market statistics, including thyroid cancer diagnostics industry global market size, regional shares, competitors with a thyroid cancer diagnostics market share, detailed thyroid cancer diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the thyroid cancer diagnostics industry. This thyroid cancer diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The thyroid cancer diagnostics market size has grown strongly in recent years. It will grow from $2.99 billion in 2024 to $3.16 billion in 2025 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to increasing prevalence of thyroid cancer, aging population, rising awareness and early detection, government initiatives and funding, improved healthcare infrastructure

The thyroid cancer diagnostics market size is expected to see strong growth in the next few years. It will grow to $4.01 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to growing demand for companion diagnostics, increasing patient preference for personalized medicine, economic growth and healthcare spending, physician education and training, regulatory approvals and clearances. Major trends in the forecast period include liquid biopsies, globalization of diagnostic technologies, technological advancements, research and development, integration of artificial intelligence, collaborations and partnerships.

The anticipated increase in thyroid cancer cases is set to drive the expansion of the thyroid cancer diagnostic market. Thyroid cancer, a condition affecting the thyroid gland, necessitates early detection for improved treatment outcomes. Diagnostic tools play a crucial role in identifying thyroid cancer at an early stage, meeting the rising demand for effective diagnostic solutions. According to a September 2023 report by the American Cancer Society, an estimated 43,720 new cases of thyroid cancer are expected in 2023, emphasizing the need for diagnostic advancements. The report further projects approximately 2,120 deaths from thyroid cancer in the same year. Consequently, the escalating prevalence of thyroid cancer is a significant driver propelling the thyroid cancer diagnostic market.

The growth of healthcare spending is poised to further boost the thyroid cancer diagnostics market. Healthcare spending, encompassing financial resources allocated to healthcare provision, is a key factor influencing diagnostic market dynamics. The increased investment in healthcare contributes to the research, development, and implementation of advanced diagnostic technologies. This investment enhances accessibility and affordability of innovative tools, fostering early detection and improved management of thyroid cancer. As indicated in the 2021-2030 National Health Expenditure report by the Centers for Medicare & Medicaid Services, the projected annual growth in national health spending is expected to reach 5.1% between 2021 and 2030, totaling nearly $6.8 trillion. With specific focus on Medicare and Medicaid, spending is anticipated to rise at rates of 7.2% and 5.6% annually, respectively. Thus, increased healthcare spending is a key driver fueling the growth of the thyroid cancer diagnostics market.

Major companies in the thyroid cancer diagnostic market are focusing on developing innovative solutions, such as RNA sequencing tests, to improve the accuracy of cancer fusion detection across various solid tumors, including thyroid cancer. RNA sequencing (RNA-Seq) is a high-throughput technique that allows for the analysis of RNA quantity and sequence in a sample, offering insights into gene expression and the overall transcriptome. For example, in March 2024, Foundation Medicine, Inc., a US-based biotechnology company, announced the U.S. launch of FoundationOne RNA, a tissue-based RNA sequencing test designed to detect cancer-related gene fusions across 318 genes. This test provides fusion reporting for all solid tumors and may be especially useful for identifying fusions in cancers such as non-small cell lung cancer (NSCLC), sarcoma, pancreatic cancer, thyroid cancer, cholangiocarcinoma, and bladder cancer.

Major companies in the thyroid cancer diagnostic market are also focusing on the development of innovative products, such as rearranged during transfection (RET) inhibitors. RET inhibitors specifically target and inhibit the activity of the RET protein. CStone Pharmaceuticals gained approval for GAVRETO (pralsetinib) in March 2022. GAVRETO is a selective RET inhibitor sanctioned in China for managing RET-mutant medullary thyroid cancer (MTC) and RET fusion-positive thyroid cancer (TC). This oral targeted therapy addresses the needs of patients with various forms of thyroid cancer, contributing to enhanced diagnostic and treatment options.

In September 2024, The World Tumor Registry (WTR), a US-based non-profit organization focused on the collection and analysis of tumor data, partnered with PathPresenter. This collaboration supports WTR's mission to develop an accessible educational resource for cancer care and research organizations globally, offering a secure and scalable solution to improve cancer diagnostics and education. PathPresenter is a US-based multi-tenant enterprise pathology workflow software platform.

Major companies operating in the thyroid cancer diagnostics market include Pfizer Inc., General Electric, F. Hoffmann-La Roche AG, Bayer AG, Novartis International AG, Sanofi S.A., Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Abbott Laboratories, GlaxoSmithKline plc, Eli Lilly and Company, Toshiba Corporation, Merck KGaA, Siemens Healthcare GmbH, FUJIFILM Holdings Corporation, Koninklijke Philips N.V., AstraZeneca plc, Agilent Technologies Inc., Hologic Inc., Genzyme Corporation, Illumina Inc., BioMerieux SA, Bio-Rad Laboratories Inc., Quest Diagnostics Inc., Qiagen N.V., Cepheid, Veracyte Inc., DiaSorin S.p.A., Myriad Genetics Inc.

North America was the largest region in the thyroid cancer diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the thyroid cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the thyroid cancer diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The thyroid cancer diagnostics market includes revenues earned by entities by providing diagnostic tools related detection and diagnosis of thyroid cancer, radioactive tracer, biopsy, blood tests. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Thyroid Cancer Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on thyroid cancer diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for thyroid cancer diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The thyroid cancer diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Technique Type: Imaging Test; Blood Test; Biopsy; Other Test Type
• 2) By Disease Type: Papillary Carcinoma; Follicular Carcinoma; Other Diseases
• 3) By End-User: Hospital Laboratories; Cancer Diagnostic Centers; Research Institutes; Other End-Users
• Subsegments:
• 1) By Imaging Test: Ultrasound Imaging; Computed Tomography (CT) Scans; Magnetic Resonance Imaging (MRI); Positron Emission Tomography (PET) Scans; Radioactive Iodine Scans
• 2) By Blood Test: Thyroid Function Tests; Tumor Marker Tests; Genetic Testing For Thyroid Cancer
• 3) By Biopsy: Fine Needle Aspiration (FNA) Biopsy; Core Needle Biopsy; Surgical Biopsy
• 4) By Other Test Type: Molecular Diagnostics; Immunohistochemistry Tests; Histopathological Analysis
• Companies Mentioned: Pfizer Inc.; General Electric; F. Hoffmann-La Roche AG; Bayer AG; Novartis International AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Thyroid Cancer Diagnostics Market Characteristics

3. Thyroid Cancer Diagnostics Market Trends And Strategies

4. Thyroid Cancer Diagnostics Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Thyroid Cancer Diagnostics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Thyroid Cancer Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Thyroid Cancer Diagnostics Market Growth Rate Analysis
• 5.4. Global Thyroid Cancer Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Thyroid Cancer Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Thyroid Cancer Diagnostics Total Addressable Market (TAM)

6. Thyroid Cancer Diagnostics Market Segmentation

• 6.1. Global Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Imaging Test
• Blood Test
• Biopsy
• Other Test Type
• 6.2. Global Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Papillary Carcinoma
• Follicular Carcinoma
• Other Diseases
• 6.3. Global Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Laboratories
• Cancer Diagnostic Centers
• Research Institutes
• Other End-Users
• 6.4. Global Thyroid Cancer Diagnostics Market, Sub-Segmentation Of Imaging Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ultrasound Imaging
• Computed Tomography (CT) Scans
• Magnetic Resonance Imaging (MRI)
• Positron Emission Tomography (PET) Scans
• Radioactive Iodine Scans
• 6.5. Global Thyroid Cancer Diagnostics Market, Sub-Segmentation Of Blood Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Thyroid Function Tests
• Tumor Marker Tests
• Genetic Testing For Thyroid Cancer
• 6.6. Global Thyroid Cancer Diagnostics Market, Sub-Segmentation Of Biopsy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fine Needle Aspiration (FNA) Biopsy
• Core Needle Biopsy
• Surgical Biopsy
• 6.7. Global Thyroid Cancer Diagnostics Market, Sub-Segmentation Of Other Test Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Molecular Diagnostics
• Immunohistochemistry Tests
• Histopathological Analysis

7. Thyroid Cancer Diagnostics Market Regional And Country Analysis

• 7.1. Global Thyroid Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Thyroid Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Thyroid Cancer Diagnostics Market

• 8.1. Asia-Pacific Thyroid Cancer Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Thyroid Cancer Diagnostics Market

• 9.1. China Thyroid Cancer Diagnostics Market Overview
• 9.2. China Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Thyroid Cancer Diagnostics Market

• 10.1. India Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Thyroid Cancer Diagnostics Market

• 11.1. Japan Thyroid Cancer Diagnostics Market Overview
• 11.2. Japan Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Thyroid Cancer Diagnostics Market

• 12.1. Australia Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Thyroid Cancer Diagnostics Market

• 13.1. Indonesia Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Thyroid Cancer Diagnostics Market

• 14.1. South Korea Thyroid Cancer Diagnostics Market Overview
• 14.2. South Korea Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Thyroid Cancer Diagnostics Market

• 15.1. Western Europe Thyroid Cancer Diagnostics Market Overview
• 15.2. Western Europe Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Thyroid Cancer Diagnostics Market

• 16.1. UK Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Thyroid Cancer Diagnostics Market

• 17.1. Germany Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Thyroid Cancer Diagnostics Market

• 18.1. France Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Thyroid Cancer Diagnostics Market

• 19.1. Italy Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Thyroid Cancer Diagnostics Market

• 20.1. Spain Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Thyroid Cancer Diagnostics Market

• 21.1. Eastern Europe Thyroid Cancer Diagnostics Market Overview
• 21.2. Eastern Europe Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Thyroid Cancer Diagnostics Market

• 22.1. Russia Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Thyroid Cancer Diagnostics Market

• 23.1. North America Thyroid Cancer Diagnostics Market Overview
• 23.2. North America Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Thyroid Cancer Diagnostics Market

• 24.1. USA Thyroid Cancer Diagnostics Market Overview
• 24.2. USA Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Thyroid Cancer Diagnostics Market

• 25.1. Canada Thyroid Cancer Diagnostics Market Overview
• 25.2. Canada Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Thyroid Cancer Diagnostics Market

• 26.1. South America Thyroid Cancer Diagnostics Market Overview
• 26.2. South America Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Thyroid Cancer Diagnostics Market

• 27.1. Brazil Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Thyroid Cancer Diagnostics Market

• 28.1. Middle East Thyroid Cancer Diagnostics Market Overview
• 28.2. Middle East Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Thyroid Cancer Diagnostics Market

• 29.1. Africa Thyroid Cancer Diagnostics Market Overview
• 29.2. Africa Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Thyroid Cancer Diagnostics Market Competitive Landscape And Company Profiles

• 30.1. Thyroid Cancer Diagnostics Market Competitive Landscape
• 30.2. Thyroid Cancer Diagnostics Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. General Electric Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Novartis International AG Overview, Products and Services, Strategy and Financial Analysis

31. Thyroid Cancer Diagnostics Market Other Major And Innovative Companies

• 31.1. Sanofi S.A.
• 31.2. Bristol-Myers Squibb Company
• 31.3. Thermo Fisher Scientific Inc.
• 31.4. Abbott Laboratories
• 31.5. GlaxoSmithKline plc
• 31.6. Eli Lilly and Company
• 31.7. Toshiba Corporation
• 31.8. Merck KGaA
• 31.9. Siemens Healthcare GmbH
• 31.10. FUJIFILM Holdings Corporation
• 31.11. Koninklijke Philips N.V.
• 31.12. AstraZeneca plc
• 31.13. Agilent Technologies Inc.
• 31.14. Hologic Inc.
• 31.15. Genzyme Corporation

32. Global Thyroid Cancer Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Thyroid Cancer Diagnostics Market

34. Recent Developments In The Thyroid Cancer Diagnostics Market

35. Thyroid Cancer Diagnostics Market High Potential Countries, Segments and Strategies

• 35.1 Thyroid Cancer Diagnostics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Thyroid Cancer Diagnostics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Thyroid Cancer Diagnostics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer